<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01118221</url>
  </required_header>
  <id_info>
    <org_study_id>O7467-R</org_study_id>
    <nct_id>NCT01118221</nct_id>
  </id_info>
  <brief_title>Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients</brief_title>
  <official_title>Rehabilitation of IPF Patients: Effects of Exercise and Oxidant Stress</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The incidence and prevalence of IPF increase exponentially with age, and IPF occurs more
      often in older males. Cigarette smoking and environmental dust exposures are known risk
      factors for developing IPF. For example, the recently deployed military population, as it
      ages, is at especially increased risk of IPF. No effective therapies exist, although lung
      transplantation is used to extend survival of selected patients.

      Defining specific therapy to improve exercise tolerance and dyspnea in IPF patients is thus
      an urgent priority of veteran-oriented research programs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic lung disease is common in the veteran population. While chronic obstructive pulmonary
      disease (COPD) is most prominent, fibrotic lung diseases, typified by idiopathic pulmonary
      fibrosis (IPF), are clearly increasing. We have developed extensive experience with a VA
      idiopathic pulmonary fibrosis (IPF) population in the context of a randomized, controlled
      clinical trial of vasodilator therapy.

      Based on the current literature and our preliminary experience with exercise testing in IPF
      patients, we hypothesize that:

        1. Formal pulmonary rehabilitation (i.e., an aerobic exercise program) will result in
           improved outcomes for IPF patients, demonstrable as an:

             1. Increase in exercise tolerance as quantified by 6-minute walk test (MWT) distance;

             2. Decrease in post-exercise dyspnea as quantified by the Borg dyspnea scale; and an

             3. Overall subjective improvement in quality of life as quantified by Saint George's
                Respiratory Questionnaire.

        2. Metabolic and physiologic mechanisms of improved exercise tolerance and decreased
           dyspnea will include:

             1. More efficient oxygen metabolism demonstrated by maximum O2 uptake (VO2max);

             2. Decreased post-exercise oxidant stress demonstrated by post-exercise isoprostanes
                and plasma total antioxidant capacity (TAC); and,

             3. Maintenance of maximum inspiratory and expiratory pressures (PInmax and PExmax).

      Our Specific Objectives are:

        1. To investigate formal pulmonary rehabilitation and exercise tolerance in IPF patients

           The following important endpoints will be assessed to test the working hypothesis that
           pulmonary rehabilitation improves exercise capacity and lessens dyspnea:

             1. 6-MWT distance;

             2. Dyspnea index; and,

             3. Quality of life (Saint George's Respiratory Questionnaire [SGRQ] and International
                Physical Activity Questionnaire [IPAQ]).

        2. To assess changes in oxygen uptake, markers of oxidant stress and pulmonary function
           resulting from pulmonary rehabilitation

      To test the working hypothesis that improved outcomes are associated with more efficient O2
      utilization, decreased markers of oxidant stress and maintained effort dependent pulmonary
      function, the following variables will be measured:

        1. Peak oxygen uptake (VO2peak) during constant load exercise;

        2. Markers of oxidant stress, including plasma and urine isoprostanes; and,

        3. Maximum inspiratory and expiratory pressures (PInmax and PExmax). Completion of these
           Specific Objectives will position our research group to conduct future studies of 1)
           mechanisms of exercise limitation and 2) antioxidant therapies, both in this defined
           population and those who are at risk of developing pulmonary fibrosis. The long term
           impact of this application is thus to develop effective pulmonary rehabilitation
           strategies for IPF patients, based on knowledge of underlying changes in oxygen
           metabolism and oxidant stress.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6 Minute Walk Distance</measure>
    <time_frame>The 6-MWD will be measured at 0 and 3 months.</time_frame>
    <description>Change in 6 Minute Walk Distance from Baseline to 3 Months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systemic Markers of Oxidant Stress</measure>
    <time_frame>Markers of oxidant stress will be measured in all subjects before randomization after exercise testing at 0 months.</time_frame>
    <description>Plasma F2-isoprostanes measured in all subjects before and after exercise testing at baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum Oxygen Uptake</measure>
    <time_frame>Maximum O2 uptake will be measured at 0 and 3 months.</time_frame>
    <description>Change in 6 peak O2 uptake from Baseline to 3 Months</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Idiopathic Pulmonary Fibrosis</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>enroll in pulmonary rehabilitation program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no structured exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>pulmonary rehabilitation</intervention_name>
    <description>structured exercise program</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical presentation consistent with IPF with onset between three months and 48
             months prior to screening.

          -  Diagnosis made by high-resolution computed tomographic scan showing highly probable
             IPF.

          -  Absence of severe pulmonary hypertension (i.e., PAsys must be less than 55 mm Hg,
             based on echocardiography) and absence of decompensated right heart failure (NYHA
             class I or II acceptable).

          -  Age 40 through 80, inclusive.

          -  Abnormal pulmonary function tests (FVC 40-90% predicted or DLCO 30-90% predicted or
             impaired gas exchange with rest or exercise).

          -  Six-minute walk distance 150 m and 500 m.

          -  Worsening as demonstrated by any one of the following within the past year: &gt; 10%
             decrease in percent predicted forced vital capacity or worsening dyspnea at rest or
             upon exertion, based on history.

          -  Ability to understand and sign a written informed consent form and comply with the
             requirements of the study.

          -  Absence of clinical features suggesting infection, neoplasm, sarcoidosis or
             collagen-vascular disease.

        Exclusion Criteria:

          -  Echocardiographic evidence of severe pulmonary hypertension (PAsys&gt;55 mm Hg, based on
             echocardiography or TR velocity 3.2 m/sec).

          -  Severe heart failure (NYHA class III or IV or LVEF &lt; 45%).

          -  Six-minute walk distance &lt; 150 m or &gt; 500 m.

          -  FEV1/FVC ratio &lt; 0.7 at screening (post-bronchodilator).

          -  Residual volume &gt; 100% predicted.

          -  Any condition other than IPF likely to result in the death of the participant within
             the next two years.

          -  History of unstable or deteriorating cardiac or neurologic disease.

          -  Pregnancy or lactation. Patients who are: (a) pregnant or (b) breast feeding are
             excluded from the study.

          -  Current treatment with corticosteroids (either oral or inhaled), Cytoxan,
             azathioprine, colchicine, pirfenidone, anti-tumor necrosis factor therapy or
             endothelin receptor blockers. Prior treatment is permitted, but at least four weeks of
             treatment washout prior to inclusion in this study are required.

          -  Investigational therapy for any indication within 28 days prior to enrollment.

          -  Degenerative arthritis, cerebrovascular accident or other limitation to mobility
             preventing completion of the 6-minute walk test.

          -  Oxygen saturation on room air &lt;80% at rest.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert M Jackson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Medical Center, Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Medical Center, Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Jackson RM, Gómez-Marín OW, Ramos CF, Sol CM, Cohen MI, Gaunaurd IA, Cahalin LP, Cardenas DD. Exercise limitation in IPF patients: a randomized trial of pulmonary rehabilitation. Lung. 2014 Jun;192(3):367-76. doi: 10.1007/s00408-014-9566-9. Epub 2014 Apr 5.</citation>
    <PMID>24705678</PMID>
  </results_reference>
  <results_reference>
    <citation>Gaunaurd IA, Gómez-Marín OW, Ramos CF, Sol CM, Cohen MI, Cahalin LP, Cardenas DD, Jackson RM. Physical activity and quality of life improvements of patients with idiopathic pulmonary fibrosis completing a pulmonary rehabilitation program. Respir Care. 2014 Dec;59(12):1872-9. doi: 10.4187/respcare.03180. Epub 2014 Sep 2.</citation>
    <PMID>25185149</PMID>
  </results_reference>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2010</study_first_submitted>
  <study_first_submitted_qc>May 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2010</study_first_posted>
  <results_first_submitted>November 19, 2014</results_first_submitted>
  <results_first_submitted_qc>December 29, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 16, 2015</results_first_posted>
  <last_update_submitted>February 13, 2015</last_update_submitted>
  <last_update_submitted_qc>February 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>oxidant stress</keyword>
  <keyword>exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Pulmonary Rehabilitation</title>
          <description>enroll in pulmonary rehabilitation program
pulmonary rehabilitation: structured exercise program</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>no structured exercise</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Pulmonary Rehabilitation</title>
          <description>enroll in pulmonary rehabilitation program
pulmonary rehabilitation: structured exercise program</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>no structured exercise</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="25"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71" spread="6"/>
                    <measurement group_id="B2" value="66" spread="7"/>
                    <measurement group_id="B3" value="69" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>South America</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>6 Minute Walk Distance</title>
        <description>Change in 6 Minute Walk Distance from Baseline to 3 Months</description>
        <time_frame>The 6-MWD will be measured at 0 and 3 months.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>enroll in pulmonary rehabilitation program
pulmonary rehabilitation: structured exercise program</description>
          </group>
          <group group_id="O2">
            <title>Arm 2</title>
            <description>no structured exercise</description>
          </group>
        </group_list>
        <measure>
          <title>6 Minute Walk Distance</title>
          <description>Change in 6 Minute Walk Distance from Baseline to 3 Months</description>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.2" spread="86.9"/>
                    <measurement group_id="O2" value="-15.3" spread="42.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Systemic Markers of Oxidant Stress</title>
        <description>Plasma F2-isoprostanes measured in all subjects before and after exercise testing at baseline.</description>
        <time_frame>Markers of oxidant stress will be measured in all subjects before randomization after exercise testing at 0 months.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Before Exercise Testing</title>
            <description>Plasma isoprostanes before exercise test.</description>
          </group>
          <group group_id="O2">
            <title>After Exercise Testing</title>
            <description>Plasma isoprostanes after exercise testing.</description>
          </group>
        </group_list>
        <measure>
          <title>Systemic Markers of Oxidant Stress</title>
          <description>Plasma F2-isoprostanes measured in all subjects before and after exercise testing at baseline.</description>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.48" spread="10.10"/>
                    <measurement group_id="O2" value="17.96" spread="10.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximum Oxygen Uptake</title>
        <description>Change in 6 peak O2 uptake from Baseline to 3 Months</description>
        <time_frame>Maximum O2 uptake will be measured at 0 and 3 months.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Rehabilitation Group</title>
            <description>enroll in pulmonary rehabilitation program
pulmonary rehabilitation: structured exercise program</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>no structured exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Maximum Oxygen Uptake</title>
          <description>Change in 6 peak O2 uptake from Baseline to 3 Months</description>
          <units>mL/minute</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-35" spread="71"/>
                    <measurement group_id="O2" value="-119" spread="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Six months.</time_frame>
      <desc>Adverse and unexpected events were recorded.</desc>
      <group_list>
        <group group_id="E1">
          <title>Arm 1</title>
          <description>enroll in pulmonary rehabilitation program
pulmonary rehabilitation: structured exercise program</description>
        </group>
        <group group_id="E2">
          <title>Arm 2</title>
          <description>no structured exercise</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Robert M Jackson, MD</name_or_title>
      <organization>MVAHS</organization>
      <phone>305-575-3548</phone>
      <email>robert.jackson4@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

